Results 221 to 230 of about 111,563 (381)
ABSTRACT Introduction Individuals hospitalized with depression are particularly impacted by cognitive impairment. Identifying variables that predict improvements in cognition across treatment may inform more targeted and effective treatment approaches. We conducted secondary analyses to investigate baseline predictors of objective cognitive change in a
Zoe A. Odering +5 more
wiley +1 more source
A 10-year retrospective cross-sectional study of severe cutaneous adverse drug reactions in Thailand: Human leukocyte antigen typing and enzyme-linked immunospot assay-assisted drug identification. [PDF]
Wongtada C +20 more
europepmc +1 more source
Clinical Pharmacokinetics of Zanisamide and Drug Interaction with Other Anticonvulsants.
Yoshio Ijiri +6 more
openalex +2 more sources
Lifetime Mixed Depression and Childhood Trauma in Individuals With Bipolar Disorders
ABSTRACT Background and Aims Mixed Depression (MxD), characterized by the co‐occurrence of depressive and excitatory symptoms, is a prevalent yet often underdiagnosed presentation in bipolar disorders (BD), with significant implications for prognosis and treatment. Childhood trauma is a key environmental risk factor associated with a more severe course
Francesca Bardi +8 more
wiley +1 more source
Treatment patterns in women with breast cancer and endocrine therapy-related menopausal symptoms: a cohort study from the United States, United Kingdom, and Germany. [PDF]
Saadedine M +11 more
europepmc +1 more source
ANTICONVULSANT POTENCY OF 10 VARIOUS P-ISOPROPOXYPHENYLSUCCINIMIDE DERIVATIVES IN THE MAXIMAL ELECTROSHOCK-INDUCED SEIZURE THRESHOLD MODEL IN MICE [PDF]
S. L. Kocharov +6 more
openalex +1 more source
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley +1 more source

